NSF Funds 4 New Engineering Research Centers
NSF invests $104M in new engineering centers to advance biotechnology, robotics, and sustainability.
- Latest
- Trending
NSF invests $104M in new engineering centers to advance biotechnology, robotics, and sustainability.
European biotech set to soar with digital tech aiding sustainable innovations and industrial processes.
Biotech sees stable funding as 2024 venture capital and IPOs rise. Investors focus on late-stage assets amid economic challenges.
AI-designed proteins transform with molecular switches, paving new paths in biotechnology innovation and drug delivery.
Genmab's H1 2024 results show 36% revenue growth; DARZALEX sales surge, and strategic acquisition of ProfoundBio boosts future potential.
Companies must adapt as U.S. advances biotech bill restricting Chinese suppliers.
Explore top biotech ETFs like XBI, BBH, and IBB, offering potential returns and portfolio diversification in a growing market.
Beam Therapeutics leads with CRISPR in treating genetic diseases, opening new market avenues.
Trinity Biotech will release its Q2 2024 financial results on August 14, 2024, with a call at 8:30 AM ET ...
IO Biotech's Q2 2024 EPS beats estimates, reporting -31 cents vs. expected -35 cents, despite no revenue.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.